Edwards Lifesciences (EW) PT Raised to $101 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St futures up as oil slips; telecoms pressured by SpaceX spectrum deal
- Oil falls as Trump comments on Iran talks ease supply concerns
- UBS flags level in gold prices where dip buyers will likely emerge
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- Investors need sustained Fed cuts to move cash off sidelines: BofA's Hartnett
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $84.24 --0%
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 11 | New: 28
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 11 | New: 28
Join SI Premium – FREE
Truist Securities analyst Richard Newitter raised the price target on Edwards Lifesciences (NYSE: EW) to $101.00 (from $97.00) while maintaining a Buy rating.
You May Also Be Interested In
- UBS Reiterates Buy Rating on Edwards Lifesciences (EW)
- Evergy (EVRG) PT Lowered to $93 at RBC Capital
- Tata Steel Ltd (TATA:IN) PT Lowered to INR210 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
